Jetstream Atherectomy with Paclitaxel-Coated Balloons: Two-Year Outcome of the Prospective Randomized JET-RANGER Study
Vascular Health and Risk Management · 2023
DOI: 10.2147/vhrm.s403177 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Vascular Health and Risk Management, 2023. Verfasst von Nicolas W Shammas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Midwest Cardiovascular Research Foundation, Davenport, IA, USA. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Carcinoma, Renal Cell, Peripheral Arterial Disease, Kidney Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Midwest Cardiovascular Research Foundation, Davenport, IA, USA.
ORCID-Profile: Nicolas W Shammas, Sue Jones-Miller
Zitieren
APA
Shammas, N. W., Shammas, G., Christensen, L., Jones-Miller, S., & JET-RANGER Investigators (2023). Jetstream Atherectomy with Paclitaxel-Coated Balloons: Two-Year Outcome of the Prospective Randomized JET-RANGER Study. Vascular Health and Risk Management. https://doi.org/10.2147/vhrm.s403177
Vancouver
Shammas NW, Shammas G, Christensen L, Jones-Miller S, JET-RANGER Investigators. Jetstream Atherectomy with Paclitaxel-Coated Balloons: Two-Year Outcome of the Prospective Randomized JET-RANGER Study. Vascular Health and Risk Management. 2023. doi:10.2147/vhrm.s403177
BibTeX
@article{Shammas2023,
author = {Shammas, Nicolas W and Shammas, Gail and Christensen, Lori and Jones-Miller, Sue and JET-RANGER Investigators, JET-RANGER Investigators},
title = {Jetstream Atherectomy with Paclitaxel-Coated Balloons: Two-Year Outcome of the Prospective Randomized JET-RANGER Study},
journal = {Vascular Health and Risk Management},
year = {2023},
doi = {10.2147/vhrm.s403177}
}
EUVIMED